For Duchenne muscular dystrophy, a single dose of AAV9-micro dystrophin (5E + 13vg/kg) was tested in non-ambulatory adolescent DMD patients and transient renal dysfunction and hematological complications appeared few days post-administration [11]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.